Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative estrogen-progestagen prevention of recurrent intrauterine adhesions after hysteroscopic adhesiolysis
NL-OMON24510Recruiting
- Sponsor
- Spaarne Gasthuis
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of DehydraTECH-estrogen in Intrauterine Adhesions (IUA) (2 arms), sponsored by Spaarne Gasthuis. Primary endpoint: Incidence and severity of intrauterine re-adhesions. Started Sep 2013; status: recruiting.
02
Drugs
DehydraTECH-estrogen
03
Conditions
Intrauterine Adhesions (IUA)
Beyond the preview
Go deeper on NL-OMON24510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24510.